GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.84M | 2.83M | 317.10K | 291.80K | 2.55M |
| Total Receivables | 1.85M | 1.85M | 1.58M | 1.45M | 2.06M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 180.80K | 180.70K | 442.70K | 407.50K | 289.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 982.70K | 982.00K | 846.70K | 779.30K | 634.60K |
| Total Current Assets | 5.85M | 5.85M | 3.19M | 2.93M | 5.53M |
|
|
|||||
| Total Current Assets | 5.85M | 5.85M | 3.19M | 2.93M | 5.53M |
| Net Property, Plant & Equipment | 501.40K | 501.00K | 816.20K | 751.20K | 965.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 0.00 | 44.60K | 41.10K | 59.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.34M | 3.34M | 4.58M | 4.22M | 4.58M |
| Total Assets | 9.69M | 9.69M | 8.63M | 7.95M | 11.14M |
|
|
|||||
| Total Accounts Payable | 6.95M | 6.95M | 10.06M | 9.26M | 6.58M |
| Total Accrued Expenses | 2.51M | 2.51M | 3.03M | 2.79M | 1.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.28M | 4.27M | 16.39M | 15.09M | 14.39M |
| Total Finance Division Other Current Liabilities | 1.14M | 1.14M | 607.20K | 558.80K | 651.20K |
| Total Other Current Liabilities | 1.14M | 1.14M | 607.20K | 558.80K | 651.20K |
| Total Current Liabilities | 14.88M | 14.86M | 30.09M | 27.69M | 23.42M |
|
|
|||||
| Total Current Liabilities | 14.88M | 14.86M | 30.09M | 27.69M | 23.42M |
| Long-Term Debt | 10.82M | 10.81M | 5.52M | 5.08M | 4.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.70K | 4.70K | 421.60K | 388.00K | 532.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.28M | 13.27M | 10.31M | 9.49M | 15.06M |
| Total Liabilities | 38.98M | 38.95M | 46.34M | 42.65M | 39.01M |
|
|
|||||
| Common Stock & APIC | 261.74M | 261.56M | 247.85M | 228.11M | 217.13M |
| Retained Earnings | -14.13M | -14.12M | -8.18M | -7.53M | -14.50M |
| Treasury Stock & Other | -276.90M | -276.70M | -277.37M | -255.28M | -230.50M |
| Total Common Equity | -29.29M | -29.26M | -37.71M | -34.70M | -27.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.29M | -29.26M | -37.71M | -34.70M | -27.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.29M | -29.26M | -37.71M | -34.70M | -27.87M |
|
|
|||||